VERACYTE, INC. current report, 22 July 2020

Business Context and Reporting Period

This Form 8-K Current Report was filed by Veracyte, Inc. on July 22, 2020. The report discloses a corporate governance event regarding the appointment of a new director to the Board of Directors.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and compensation arrangements rather than financial performance.

Material Changes

The primary material change disclosed is the appointment of Jens Holstein as a director, effective August 1, 2020. Key details include:

  • Role: Class III director with a term expiring at the 2022 annual meeting.
  • Committee Assignment: Appointed to the Audit Committee.
  • Compensation Structure:
    • Annual cash retainer of $40,000 for Board service.
    • Annual cash retainer of $10,000 for Audit Committee service.
    • Initial stock option grant for 35,000 shares at fair market value, vesting one-third annually over three years.
    • Eligibility for future annual stock option grants.

Guidance, Outlook, and Risks

The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks or contingencies are disclosed in this report, other than the standard indemnity agreement entered into by the new director.

Investor Verification Checklist

  • Verify the effective date of Jens Holstein's directorship (August 1, 2020).
  • Confirm the vesting schedule of the 35,000-share stock option grant.
  • Review the total annual cash compensation ($50,000 base) for the new director.
  • Check for any subsequent filings regarding the 2022 annual meeting where Mr. Holstein's term expires.